Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
CAMARILLO, Calif., Dec. 21, 2022 /PRNewswire/ -- Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many industry- leading...
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health – Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-powered healthcare company, signed a strategic partnership agreement to locally manufacture innovative drugs in...
CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation
BEIJING, Dec. 20, 2022 /PRNewswire/ -- China now has been enhancing its COVID-19 vaccination as a priority especially among the vulnerable groups such as elders to further cement its protection for people against the virus. This strategy is becoming more prominent as the country has loosened up its measures against the virus, which will help balance the epidemic control and...
Edan Medical UK Pointed out the Trend of Healthcare Innovation on the Interview Broadcasted on Sky TV
NORTHAMPTON, England, Dec. 20, 2022 /PRNewswire/ -- Edan Medical UK, one of the subsidiaries of Edan Instruments Inc. (300206.SZ) - a healthcare company and medical device manufacturer, shared its insights of healthcare innovation through the documentary programme: The Roadmap For Innovation In Healthcare, broadcasted on Sky TV on Dec. 11. Established in November 2017, Edan Medical UK has served...
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) and the Australian Therapeutic Goods Administration (TGA) have approved initiation of Phase 2 studies for evaluation of KP104, a first-in-class bifunctional biologic that...
The Top 8 Best Places to Work in Philippines for 2022 revealed
MANILA, Philippines , Dec. 20, 2022 /PRNewswire/ -- Amway, Fujitsu, Multicare, Novo Nordisk, Diageo, Kusum, Schindler and Universal Robina are recognized as the top 8 best places to work in Philippines for 2022 according to the annual prestigious "Best Places to Work" certification program. Amway Philippines, a local affiliate of Amway Corporation, one of the world's largest direct selling businesses...
PHASE II/III CLINICAL TRIAL OF SIMCERE’S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT
NANJING, China, Dec. 20, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced today that, XIANNUOXIN (SIM0417), an anti-SARS-CoV-2 drug candidate jointly developed by Simcere with Shanghai Institute of Materia Medica (the "SIMM") and Wuhan Institute of Virology (the "WIV"), Chinese Academy of Sciences (the "CAS"), has achieved a major clinical milestone: A multi-centered, randomized, double-blind, placebo-controlled phase II/III clinical study...
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries
SHANGHAI and MOSCOW, Dec. 20, 2022 /PRNewswire/ -- Mabwell Bioscience (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, today announced the company has entered into an licensing agreement with the Russian pharmaceutical company Binnopharm Group, for 9MW0113, 9MW0321 and 9MW0311, its Adalimumab and Denosumab biosimilars, under which Binnopharm Group will have exclusive rights to develop, register,...
Korea Ginseng Corp. enhances its reputation as a leading herbal dietary brand by revealing a new set of stocking stuffers
To commemorate its 123rd anniversary, Korea Ginseng Corp. has launched a new set of Koreselect online products, available exclusively online. This holiday season, give your loved ones the gift of CheongKwanJang! CERRITOS, Calif., Dec. 20, 2022 /PRNewswire/ -- To celebrate its 123rd anniversary, Korea Ginseng Corp., the world's number one ginseng brand, is building on its global...
CGTN: New Approaches: Why China is easing its COVID-19 curbs now
BEIJING, Dec. 20, 2022 /PRNewswire/ -- SARS-CoV-2, the virus causing COVID-19, mutates constantly. Since the beginning of the pandemic three years ago, the virus has hit the world with different faces – Alpha, Beta, Delta, Gamma and then Omicron – taking away millions of lives. Wu Zunyou, chief epidemiologist at the Chinese Center for Disease Control and Prevention, said on Saturday...
